MYOVIEW 30ML DIN 02422158
Health Canada record
| Active ingredient(s) | TETROFOSMIN 1.38 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09GA02 TECHNETIUM (99m Tc) TETROFOSMIN |
| Original market date | 09-Jul-2014 |
| Current status date | 27-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
GE Healthcare Canada Inc. — licence 101469, currently licensed, last inspection rating C (2023-02-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TETROFOSMIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02328755 | MYOVIEW | GE HEALTHCARE CANADA INC | Powder For Solution | TETROFOSMIN 0.23 MG | Marketed |